Regulatory effect of histamine H1 receptor antagonist on the expression of messenger RNA encoding CC chemokines in the human nasal mucosa

Journal of Allergy and Clinical Immunology

Volumn 107, Issue 1, 2001, Pages 123-128

  Fujikura, Terumichi ^a   Shimosawa, Tatsuo ^b   Yakuo, Ikuhisa ^c  

^a NIPPON MEDICAL SCHOOL   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c DAINIPPON SUMITOMO PHARMA CO LTD   (Japan)

Author keywords

Carebastine; CC chemokine; Eotaxin; Histamine; Monocyte chemotactic protein 1; Monocyte chemotactic protein 3; Nasal allergy; RANTES

Indexed keywords

CAREBASTINE; CHEMOKINE; EOTAXIN; HISTAMINE; HISTAMINE H1 RECEPTOR ANTAGONIST; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; MONOCYTE CHEMOTACTIC PROTEIN 3; RANTES;

ADULT; ALLERGIC RHINITIS; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CULTURE MEDIUM; DRUG EFFECT; FEMALE; HUMAN; HUMAN TISSUE; INFLAMMATORY CELL; MALE; MITE; NOSE ALLERGY; NOSE MUCOSA; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 0035141719     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1067/mai.2001.111236     Document Type: Article

References (33)

1. Immunohistology of the nasal mucosa following allergen-induced rhinitis
2. Mast cell and eosinophils in the allergic mucosal response to allergen challenge: Changes in distribution and signs of activation in relation to symptoms
3. Basophil influx occurs after nasal allergen challenge: Effect of topical corticosteroid pretreatment
4. Pathogenesis of allergic rhinitis
5. The chemokines: Their potential role in allergic inflammation
6. Chemokines in seasonal allergic rhinitis
7. Histamine-releasing factors and inhibitors: Historical perspectives and possible implications in human illness
8. Characterization of the human basophil response to cytokines, growth factors, and histamine releasing factors of the intercrine/chemokine family
9. Monocyte chemotactic and activating factor is a potent histamine-releasing factor for human basophils
10. Monocyte chemotactic and activating factor is a potent histamine-releasing factor for basophils
11. Cloning of the human eosinophil chemoattractant, eotaxin. Expression, receptor binding, and functional properties suggest a mechanism for the selective recruitment of eosinophils
12. High expression of the chemokine receptor CCR3 in human blood basophils
13. Monocyte chemotactic protein 3 is a most effective basophil- and eosinophil-activating chemokine
14. CC chemokines in allergic inflammation
15. Single-step method for RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction
16. Histochemical and functional characteristics of metachromatic cells in the nasal epithelium in allergic rhinitis: Studies of nasal scrapings and their dispersed cells
17. Histamine activates bronchial epithelial cells to release inflammatory cytokines in vitro
18. Monocyte chemotactic and activating factor/monocyte chemoattractant protein-1 mediated histamine release from human nasal mucosa
19. Monocyte chemotactic proteins in allergen-induced inflammation in the nasal mucosa: Effect of topical corticosteroids
20. RANTES in human allergen-induced rhinitis
21. Eotaxin mRNA and protein expression in chronic sinusitis and allergen-induced nasal responses in seasonal allergic rhinitis
22. Histamine induces interleukin-8 secretion by endothelial cells
23. Chemokines and allergic disease
24. Characterization and autoradiographic localization of histamine H1 receptors in human nasal turbinates
25. Diesel exhaust particulates upregulate histamine receptor mRNA and increase histamine-induced IL-8 and GM-CSF production in nasal epithelial cells and endothelial cells
26. 2+, and cell growth
27. The response of a human bronchial epithelial cell line to histamine: Intra cellular calcium changes and extracellular release of inflammatory mediators
28. Effect of cetirizine on human eosinophil superoxide generation, eosinophil chemotaxis and eosinophil peroxidase in vitro
29. Effect of loratadine on nitrogen dioxide-induced changes in electrical resistance and release of inflammatory mediators from cultured human bronchial epithelial cells
30. Efficacy and safety of loratadine plus pseudoephedrine in patients with seasonal allergic rhinitis and mild asthma
31. Pharmacokinetics of the H1-receptor antagonist ebastine and its active metabolite carebastine in healthy subjects
32. Selective induction of monocyte and not neutrophil-activating chemokines after influenza A virus infection
33. Important factors in the nasal manifestation of allergy